In addition to the sale, Strauss holds a range of derivative securities, including stock options with varying exercise prices and expiration dates. These options include rights to buy ordinary shares at prices ranging from $154 to $465.29, with expiration dates extending into 2034. Additionally, Strauss holds restricted stock units and deferred stock units, which are set to vest and payout in ordinary shares at future dates.This transaction is part of Strauss's ongoing management of his investment in Linde (NYSE:LIN) PLC, a leading industrial gases and engineering company. The company has maintained dividend payments for 33 consecutive years, currently yielding 1.3%. For deeper insights into Linde's valuation and financial metrics, including 12 additional key ProTips, visit InvestingPro. The company has maintained dividend payments for 33 consecutive years, currently yielding 1.3%. For deeper insights into Linde's valuation and financial metrics, including 12 additional key ProTips, visit InvestingPro.
In addition to the sale, Strauss holds a range of derivative securities, including stock options with varying exercise prices and expiration dates. These options include rights to buy ordinary shares at prices ranging from $154 to $465.29, with expiration dates extending into 2034. Additionally, Strauss holds restricted stock units and deferred stock units, which are set to vest and payout in ordinary shares at future dates.
This transaction is part of Strauss's ongoing management of his investment in Linde PLC, a leading industrial gases and engineering company.
In other recent news, Linde PLC, a global leader in industrial gases, has announced major changes in its executive leadership and strong financial performance. John Panikar, Executive Vice President-APAC, is set to retire on March 31, 2025, with Binod Patwari succeeding him as Senior Vice President-APAC from November 2024. The company has reported a 2% increase in sales to $8.4 billion in their latest earnings call, largely due to project activity and demand for liquefied natural gas infrastructure. Linde also secured a substantial $2 billion contract with Dow Chemical (NYSE:DOW), pushing its project backlog to a record high of $10 billion. For Q4 2024, Linde anticipates an earnings per share (EPS) of $3.86 to $3.96, and forecasts a full-year EPS of $15.40 to $15.50, indicating a 9-10% growth. BMO (TSX:BMO) Capital Markets expressed confidence in Linde by raising its price target for the company to $507 and maintaining its Outperform rating. These are the recent developments in Linde's operations and management.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.